Rothschild & Co Asset Management US’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-92,350
Closed -$6.2M 578
2016
Q4
$6.2M Buy
92,350
+2,232
+2% +$138K 0.08% 277
2016
Q3
$5.4M Buy
90,118
+1,616
+2% +$90.1K 0.09% 268
2016
Q2
$4.43M Sell
88,502
-99,411
-53% -$4.74M 0.08% 277
2016
Q1
$8.45M Buy
187,913
+6,131
+3% +$218K 0.16% 205
2015
Q4
$7.29M Buy
181,782
+13,786
+8% +$583K 0.13% 233
2015
Q3
$8.16M Buy
167,996
+10,495
+7% +$498K 0.16% 209
2015
Q2
$7.03M Buy
+157,501
New +$6.04M 0.13% 230

Other funds holding INGN

Rothschild & Co Asset Management US's INGN Position: Q1 2017 in Review

Rothschild & Co Asset Management US sold out of Inogen (INGN) in Q1 2017, closing a stake of 92,350 shares — an estimated $6.2M sold.

Rothschild & Co Asset Management US first reported a position in INGN in Q2 2015 and held it in 7 quarters. The position peaked at $8.45M in Q1 2016. 194 funds tracked by Wall St. Rank hold INGN as of Q1 2017.

  • Rothschild & Co Asset Management US reported no remaining Inogen position as of Q1 2017 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 92,350 Inogen shares in Q1 2017, an estimated $6.2M.
  • Rothschild & Co Asset Management US first reported a position in Inogen in Q2 2015 and held it in 7 quarters.
  • Rothschild & Co Asset Management US's Inogen position peaked at $8.45M in Q1 2016.
  • 194 funds tracked by Wall St. Rank held Inogen as of Q1 2017.

Based on Rothschild & Co Asset Management US's 13F filing for Q1 2017, filed 12 May 2017.